BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals is a global biotechnology company with a strong commitment to developing innovative treatments for patients suffering from rare diseases. The company specializes in structure-guided drug design, a process that utilizes sophisticated technology and scientific expertise to create novel and effective therapies. BioCryst has successfully brought to market ORLADEYO® (berotralstat), the first oral plasma kallikrein inhibitor for the treatment of hereditary angioedema (HAE). It is currently working on expanding its portfolio with a robust pipeline of both small-molecule and protein therapies for rare diseases.

BioCryst takes pride in its commitment to patients and prioritizes building strong relationships with patient advocacy organizations. The company also emphasizes its unique company culture, fostering a collaborative and supportive environment that encourages employees to contribute their diverse perspectives and talents. BioCryst's dedication to scientific excellence and its patient-centric approach drives its mission to create a world where individuals living with rare diseases can lead fulfilling lives.

BioCryst Pharmaceuticals values work-life balance and offers its employees generous paid time off to help them achieve the perfect balance between their work and personal lives.

BioCryst Pharmaceuticals offers competitive performance-based compensation, a comprehensive health and wellness plan that includes medical, dental, vision, disability, and life insurance, as well as generous 401(k) or pension plans, equity participation, and abundant paid time off to encourage work-life balance. They also provide growth opportunities through professional development programs, and their internship program offers hands-on experience in a fast-growing biotech company.

BioCryst Pharmaceuticals is a global biotechnology company committed to improving the lives of people living with complement-mediated and other rare diseases. They leverage their expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases.

BioCryst Pharmaceuticals promotes a culture of collaboration, transparency, and support, emphasizing a "people-first" approach. They value ownership, integrity, and resilience, encouraging employees to embrace learning from setbacks and celebrating innovative thinking. Their culture is described as transparent, supportive, and human, where employees feel empowered to achieve beyond what they think is possible.

BioCryst Pharmaceuticals values diversity of all kinds, believing that diversity of thought, experience, and skill makes the company better and creates a more beautiful company culture. They actively seek and attract diversity at all levels of the company, from the Board of Directors through the management team and employees. They believe diversity is good for their business, enabling them to make better decisions for their customers, employees, and shareholders.